Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Corro Ramos

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
JMIR Cardio|August 4, 2022
Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness AnalysisFernando Albuquerque de Almeida, Isaac Corro Ramos, Maiwenn Al, et al.
Value in Health Regional Issues|April 27, 2018
Costs of Hospital Stay in Specialized Diabetic Foot Department in RussiaVictoria I Ignatyeva, Johan L Severens, Isaac Corro Ramos, et al.
Health Technology Assessment (Winchester, England)|July 18, 2024
A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic modelMarie Westwood, Nigel Armstrong, Eline Krijkamp, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical DataIsaac Corro Ramos, George A K van Voorn, Pepijn Vemer, et al.
BMJ Open|August 5, 2021
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based studyMartine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2019
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified MedicineMartine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin, et al.
Pharmacoeconomics|May 29, 2019
Severity-Adjusted Probability of Being Cost EffectiveMatthijs M Versteegh, Isaac Corro Ramos, Nasuh C Buyukkaramikli, et al.
Health Technology Assessment (Winchester, England)|June 24, 2017
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysisMarie Westwood, Isaac Corro Ramos, Shona Lang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2019
Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial resultsMartine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin, et al.
Applied Health Economics and Health Policy|September 20, 2015
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic ModellingGeorge A K van Voorn, Pepijn Vemer, Dominique Hamerlijnck, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
JMIR Cardio|August 4, 2022
Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness AnalysisFernando Albuquerque de Almeida, Isaac Corro Ramos, Maiwenn Al, et al.
Value in Health Regional Issues|April 27, 2018
Costs of Hospital Stay in Specialized Diabetic Foot Department in RussiaVictoria I Ignatyeva, Johan L Severens, Isaac Corro Ramos, et al.
Health Technology Assessment (Winchester, England)|July 18, 2024
A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic modelMarie Westwood, Nigel Armstrong, Eline Krijkamp, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical DataIsaac Corro Ramos, George A K van Voorn, Pepijn Vemer, et al.
BMJ Open|August 5, 2021
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based studyMartine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2019
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified MedicineMartine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin, et al.
Pharmacoeconomics|May 29, 2019
Severity-Adjusted Probability of Being Cost EffectiveMatthijs M Versteegh, Isaac Corro Ramos, Nasuh C Buyukkaramikli, et al.
Health Technology Assessment (Winchester, England)|June 24, 2017
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysisMarie Westwood, Isaac Corro Ramos, Shona Lang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2019
Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial resultsMartine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin, et al.
Applied Health Economics and Health Policy|September 20, 2015
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic ModellingGeorge A K van Voorn, Pepijn Vemer, Dominique Hamerlijnck, et al.
Pageof 4